Quotation
“One of the biggest challenges to medicine is the incorporation of information technology in our practices.”
“One of the biggest challenges to medicine is the incorporation of information technology in our practices.”
We’ve been trying to go a step ahead of the curve in developing practical solutions for Pharma & Cosmetic, while keeping high standards of quality through continuous dedication and innovative ideas. AZENIS in Azerbaijan, which had overcome a decade of difficulties to become one of the largest producers of many different pharmaceutical products from the Middle Eastern Region, has evolved into an international success story.
In the current business environment, all our personnel are united in their pursuit of leadership through hard work and resolve to revive Middle East businesses. A growing team of talented people with competencies in finance, pharmaceuticals, product development, mechanical engineering and sales have been set up.
we burn both candles at ends for producing all different drug classifications like Oncology, Antibiotic and etc. In this term, we make many contracts with many different suppliers for importing API from four corner of the world. Our aim is providing a reasonable quantity of pharmaceutical productions for inner requests at the first, and then export them to neighbors of Azerbaijan. Moreover, we have been already trying to achieve EU-GMP. This certificate, high technology facilities and expert manpower let us to make our dream for exporting our pharmaceutical productions to 5 continents is for long terms.
maintains global quality standards for consistent products/services
WHO-GMP ensures quality in pharmaceutical manufacturing.
Turkmenistan, Georgia, Turkey and Kazakhstan
India, China, UK, Russia and Italy
Our company has been established on the basis of our commitment to making a difference in people lives by providing quality medicines and supporting them every day. In the Middle East and Azerbaijan, we have established our branded generics business more than 5 years ago. We have gone from these humble beginnings to a multinational pharmaceutical business with over $2 million in sales.
